Histamine induces human β-defensin-3 production in human keratinocytes

Journal of Dermatological Science

Volumn 56, Issue 2, 2009, Pages 121-127

  Ishikawa, Takeko ^a   Kanda, Naoko ^a   Hau, Carren S ^b   Tada, Yayoi ^b   Watanabe, Shinichi ^a  

^a TEIKYO UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^b UNIVERSITY OF TOKYO   (Japan)

Author keywords

Activator protein 1; Histamine; Human defensin 3; Keratinocyte; Signal transducer and activator of transcription 3

Indexed keywords

2 (2 AMINO 3 METHOXYPHENYL)CHROMONE; ANTISENSE OLIGONUCLEOTIDE; BETA DEFENSIN 3; HISTAMINE; JANUS KINASE 2; MEPYRAMINE; MESSENGER RNA; N BENZYL 2 CYANO 3 (3,4 DIHYDROXYPHENYL)ACRYLAMIDE; PROTEIN C FOS; PROTEIN C JUN; SERINE; STAT3 PROTEIN; TRANSCRIPTION FACTOR AP 1; TYROSINE;

ANTIINFLAMMATORY ACTIVITY; ANTIMICROBIAL ACTIVITY; ARTICLE; CONTROLLED STUDY; ENZYME ACTIVITY; ENZYME LINKED IMMUNOSORBENT ASSAY; HUMAN; HUMAN CELL; IN VITRO STUDY; KERATINOCYTE; NEWBORN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; PROTEIN SECRETION; PROTEIN SYNTHESIS INHIBITION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; WESTERN BLOTTING; WOUND HEALING;

BETA-DEFENSINS; BLOTTING, WESTERN; CELLS, CULTURED; ENZYME-LINKED IMMUNOSORBENT ASSAY; FLAVONOIDS; HISTAMINE; HISTAMINE H1 ANTAGONISTS; HUMANS; INFANT, NEWBORN; JANUS KINASE 2; KERATINOCYTES; MALE; MAP KINASE KINASE KINASES; PHOSPHORYLATION; PROTEIN KINASE INHIBITORS; PYRILAMINE; RECEPTORS, HISTAMINE H1; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA INTERFERENCE; SIGNAL TRANSDUCTION; STAT3 TRANSCRIPTION FACTOR; TRANSCRIPTION FACTOR AP-1; TRANSCRIPTIONAL ACTIVATION; TRANSFECTION; TYROSINE; TYRPHOSTINS; UP-REGULATION;

EID: 70349810859     PISSN: 09231811     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jdermsci.2009.07.012     Document Type: Article

References (48)

1. De Jongh G.J., Zeeuwen P.L., Kucharekova M., Pfundt R., van der Valk P.G., Blokx W., et al. High expression levels of keratinocyte antimicrobial proteins in psoriasis compared with atopic dermatitis. J Invest Dermatol 125 (2005) 1163-1173
2. Niyonsaba F., Ushio H., Nakano N., Ng W., Sayama K., Hashimoto K., et al. Antimicrobial peptides human β-defensins stimulate epidermal keratinocyte migration, proliferation and production of proinflammatory cytokines and chemokines. J Invest Dermatol 127 (2007) 594-604
3. Sawamura D., Goto M., Shibaki A., Akiyama M., McMillan J.R., Abiko Y., et al. β defensin-3 engineered epidermis shows highly protective effect for bacterial infection. Gene Ther 12 (2005) 857-861
4. Kisich K.O., Howell M.D., Boguniewicz M., Heizer H.R., Watson N.U., and Leung D.Y. The constitutive capacity of human keratinocytes to kill Staphylococcus aureus is dependent on β-defensin 3. J Invest Dermatol 127 (2007) 2368-2380
5. Röhrl J., Yang D., Oppenheim J.J., and Hehlgans T. Identification and biological characterization of mouse β-defensin 14, the orthologue of human β-defensin 3. J Biol Chem 283 (2008) 5414-5419
6. Niyonsaba F., Ushio H., Nagaoka I., Okumura K., and Ogawa H. The human β-defensins (-1, -2, -3, -4) and cathelicidin LL-37 induce IL-18 secretion through p38 and ERK MAPK activation in primary human keratinocytes. J Immunol 175 (2005) 1776-1784
7. Hirsch T., Spielmann M., Zuhaili B., Fossum M., Metzig M., Koehler T., et al. Human β-defensin-3 promotes wound healing in infected diabetic wounds. J Gene Med 11 (2009) 220-228
8. Artuc M., Hermes B., Steckelings U.M., Grützkau A., and Henz B.M. Mast cells and their mediators in cutaneous wound healing-active participants or innocent bystanders?. Exp Dermatol 8 (1999) 1-16
9. Harvima I.T., Nilsson G., Suttle M.M., and Naukkarinen A. Is there a role for mast cells in psoriasis?. Arch Dermatol Res 300 (2008) 461-478
10. Weller K., Foitzik K., Paus R., Syska W., and Maurer M. Mast cells are required for normal healing of skin wounds in mice. FASEB J 20 (2006) 2366-2368
11. Shiraishi M., Hirasawa N., Oikawa S., Kobayashi Y., and Ohuchi K. Analysis of histamine-producing cells at the late phase of allergic inflammation in rats. Immunology 99 (2000) 600-606
12. Xu X., Zhang D., Zhang H., Wolters P.J., Killeen N.P., Sullivan B.M., et al. Neutrophil histamine contributes to inflammation in mycoplasma pneumonia. J Exp Med 203 (2006) 2907-2917
13. Kobayashi M., Yoshiki R., Sakabe J., Kabashima K., Nakamura M., and Tokura Y. Expression of toll-like receptor 2, NOD2 and dectin-1 and stimulatory effects of their ligands and histamine in normal human keratinocytes. Br J Dermatol 160 (2009) 297-304
14. Kanda N., and Watanabe S. Histamine enhances the production of granulocyte-macrophage colony-stimulating factor via protein kinase Cα and extracellular signal-regulated kinase in human keratinocytes. J Invest Dermatol 122 (2004) 863-872
15. 2+-dependent protein kinase C, Raf/MEK/ERK and IKK/I κB/NF-κB signal cascades. Biochem Pharmacol 69 (2005) 433-449
16. Berclaz P.Y., Shibata Y., Whitsett J.A., and Trapnell B.C. GM-CSF, via PU.1, regulates alveolar macrophage FcγR-mediated phagocytosis and the IL-18/IFN-γ-mediated molecular connection between innate and adaptive immunity in the lung. Blood 100 (2002) 4193-4200
17. Krueger J.G. The immunologic basis for the treatment of psoriasis with new biologic agents. J Am Acad Dermatol 46 (2002) 1-23
18. Kohda F., Koga T., Uchi H., Urabe K., and Furue M. Histamine-induced IL-6 and IL-8 production are differentially modulated by IFN-γ and IL-4 in human keratinocytes. J Dermatol Sci 28 (2002) 34-41
19. q/11-subunits in constitutive and agonist-mediated signaling. Mol Pharmacol 60 (2001) 1133-1142
20. 2+-induced differentiation of mouse keratinocytes. Biochem Pharmacol 63 (2002) 1785-1796
21. Schneider E., Rolli-Derkinderen M., Arock M., and Dy M. Trends in histamine research: new functions during immune responses and hematopoiesis. Trends Immunol 23 (2002) 255-263
22. Giustizieri M.L., Albanesi C., Fluhr J., Gisondi P., Norgauer J., and Girolomoni G. H1 histamine receptor mediates inflammatory responses in human keratinocytes. J Allergy Clin Immunol 114 (2004) 1176-1182
23. Chen X., Niyonsaba F., Ushio H., Hara M., Yokoi H., Matsumoto K., et al. Antimicrobial peptides human β-defensin (hBD)-3 and hBD-4 activate mast cells and increase skin vascular permeability. Eur J Immunol 37 (2007) 434-444
24. Szukiewicz D., Klimkiewicz J., Pyzlak M., Szukiewicz A., and Maslinska D. The relationship between human β-defensin 3 (hBD3) expression and mean histamine concentration in human placental tissue. Inflamm Res 57 Suppl. 1 (2008) S69-70
25. Pernet I., Reymermier C., Guezennec A., Branka J.E., Guesnet J., Perrier E., et al. Calcium triggers β-defensin (hBD-2 and hBD-3) and chemokine macrophage inflammatory protein-3 alpha (MIP-3α/CCL20) expression in monolayers of activated human keratinocytes. Exp Dermatol 12 (2003) 755-760
26. Harder J., Bartels J., Christophers E., and Schroder J.M. Isolation and characterization of human β-defensin-3, a novel human inducible peptide antibiotic. J Biol Chem 276 (2001) 5707-5713
27. Kanda N., and Watanabe S. Leptin enhances human β-defensin-2 production in human keratinocytes. Endocrinology 149 (2008) 5189-5198
28. Kanda N., Shibata S., Tada Y., Nashiro K., Tamaki K., and Watanabe S. Prolactin enhances basal and IL-17-induced CCL20 production by human keratinocytes. Eur J Immunol 39 (2009) 996-1006
29. Kanda N., and Watanabe S. Histamine enhances the production of human β-defensin-2 in human keratinocytes. Am J Physiol Cell Physiol 293 (2007) C1916-C1923
30. 2 receptor antagonists accelerate skin barrier repair and prevent epidermal hyperplasia induced by barrier disruption in a dry environment. J Invest Dermatol 116 (2001) 261-265
31. Taylor K., Clarke D.J., McCullough B., Chin W., Seo E., Yang D., et al. Analysis and separation of residues important for the chemoattractant and antimicrobial activities of b-defensin 3. J Biol Chem 283 (2008) 6631-6639
32. Jia H.P., Schutte B.C., Schudy A., Linzmeier R., Guthmiller J.M., Johnson G.K., et al. Discovery of new human β-defensins using a genomics-based approach. Gene 263 (2001) 211-218
33. Allegretto E.A., SmealT, Angel P., Spiegelman B.M., and Karin M. DNA-binding activity of Jun is increased through its interaction with Fos. J Cell Biochem 42 (1990) 193-206
34. Ng J., and Cantrell D. STAT3 is a serine kinase target in T lymphocytes. Interleukin 2 and T cell antigen receptor signals converge upon serine 727. J Biol Chem 272 (1997) 24542-24549
35. Modesti A., Bertolozzi I., Gamberi T., Marchetta M., Lumachi C., Coppo M., et al. Hyperglycemia activates JAK2 signaling pathway in human failing myocytes via angiotensin II-mediated oxidative stress. Diabetes 54 (2005) 394-401
36. Ginsberg M., Czeko E., Müller P., Ren Z., Chen X., and Darnell Jr. J.E. Amino acid residues required for physical and cooperative transcriptional interaction of STAT3 and AP-1 proteins c-Jun and c-Fos. Mol Cell Biol 27 (2007) 6300-6308
37. Lee P.J., Camhi S.L., Chin B.Y., Alam J., and Choi A.M. AP-1 and STAT mediate hyperoxia-induced gene transcription of heme oxygenase-1. Am J Physiol Lung Cell Mol Physiol 279 (2000) L82-L175
38. Menzies B.E., and Kenoyer A. Signal transduction and nuclear responses in Staphylococcus aureus-induced expression of human β-defensin 3 in skin keratinocytes. Infect Immun 74 (2006) 6847-6854
39. Horvath C.M. STAT proteins and transcriptional responses to extracellular signals. Trends Biochem Sci 25 (2000) 496-502
40. Ancha H.R., Kurella R.R., Stewart C.A., Damera G., Ceresa B.P., and Harty R.F. Histamine stimulation of MMP-1(collagenase-1) secretion and gene expression in gastric epithelial cells: role of EGFR transactivation and the MAP kinase pathway. Int J Biochem Cell Biol 39 (2007) 2143-2152
41. Benbarek H., Mouithys-Mickalad A., Deby-Dupont G., Deby C., Grülke S., Nemmar A., et al. High concentrations of histamine stimulate equine polymorphonuclear neutrophils to produce reactive oxygen species. Inflamm Res 48 (1999) 594-601
42. Andl C.D., Mizushima T., Oyama K., Bowser M., Nakagawa H., and Rustgi A.K. EGFR-induced cell migration is mediated predominantly by the JAK-STAT pathway in primary esophageal keratinocytes. Am J Physiol Gastrointest Liver Physiol 287 (2004) G1227-G1237
43. Sakhalkar S.P., Patterson E.B., and Khan M.M. Involvement of histamine H1 and H2 receptors in the regulation of STAT-1 phosphorylation: inverse agonism exhibited by the receptor antagonists. Int Immunopharmacol 5 (2005) 1299-1309
44. Horr B., Borck H., Thurmond R., Grosch S., and Diel F. STAT1 phosphorylation and cleavage is regulated by the histamine (H4) receptor in human atopic and non-atopic lymphocytes. Int Immunopharmacol 6 (2006) 1577-1585
45. Ackermann L., and Harvima I.T. Mast cells of psoriatic and atopic dermatitis skin are positive for TNF-α and their degranulation is associated with expression of ICAM-1 in the epidermis. Arch Dermatol Res 290 (1998) 353-359
46. Numata Y., Terui T., Okuyama R., Hirasawa N., Sugiura Y., Miyoshi I., et al. The accelerating effect of histamine on the cutaneous wound-healing process through the action of basic fibroblast growth factor. J Invest Dermatol 126 (2006) 1403-1409
47. Kanda N., Shimizu T., Tada Y., and Watanabe S. IL-18 enhances IFN-γ-induced production of CXCL9, CXCL10, and CXCL11 in human keratinocytes. Eur J Immunol 37 (2007) 338-350
48. Stenderup K., Rosada C., Worsaae A., Clausen J.T., and Norman Dam T. Interleukin-20 as a target in psoriasis treatment. Ann NY Acad Sci 1110 (2007) 368-381